⌘K

Login Start Free

Home/Filings/4/0001062993-18-001261

4//SEC Filing

Mattila Jyrki 4

Accession 0001062993-18-001261

CIK 0000875622other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 6:26 PM ET

Size

5.1 KB

Accession

0001062993-18-001261

Insider Transaction Report

Form 4

Period: 2018-03-15

BIOSPECIFICS TECHNOLOGIES CORPBSTC

Director

Transactions

Award
Stock Option (Right to Buy)
2018-03-15+15,000→ 15,000 total
Exercise: $41.82Exp: 2028-03-15→ Common Stock (15,000 underlying)

Footnotes (1)

[F1]The options were granted on March 15, 2018, and will vest in four equal annual installments beginning on the first anniversary of the grant date.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

BIOSPECIFICS TECHNOLOGIES CORP

CIK 0000875622

Entity typeother

Related Parties

1

filerCIK 0001297318

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 6:26 PM ET
Size: 5.1 KB

View on SEC.gov